Bouzouita K - Search Results

1

Modulation of cisplatin chronotoxicity related to reduced glutathione in mice.

Boughattas NA, Li XM, Filipski J, Lemaigre G, Filipski E, Bouzouita K, Belhadj O, Lévi F. Boughattas NA, et al. Among authors: bouzouita k. Hum Exp Toxicol. 1996 Jul;15(7):563-72. doi: 10.1177/096032719601500703. Hum Exp Toxicol. 1996. PMID: 8818709

2

Comparative pharmacokinetics of oxaliplatin (L-OHP) and carboplatin (CBDCA) in mice with reference to circadian dosing time.

Boughattas NA, Hecquet B, Fournier C, Bruguerolle B, Trabelsi H, Bouzouita K, Omrane B, Lévi F. Boughattas NA, et al. Among authors: bouzouita k. Biopharm Drug Dispos. 1994 Dec;15(9):761-73. doi: 10.1002/bdd.2510150904. Biopharm Drug Dispos. 1994. PMID: 7888604

3

Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice.

Khedhaier A, Ben Attia M, Gadacha W, Sani M, Bouzouita K, Chouchane L, Mechkouri M, Reinberg A, Boughattas NA. Khedhaier A, et al. Among authors: bouzouita k. Chronobiol Int. 2003 Nov;20(6):1103-16. doi: 10.1081/cbi-120025532. Chronobiol Int. 2003. PMID: 14680146

4

[The optimal dosing times of corticoids].

Dridi D, Ben Attia M, Aouam K, Bouzouita K, Boughattas NA, Reinberg A. Dridi D, et al. Among authors: bouzouita k. Therapie. 2006 Mar-Apr;61(2):161-9. Therapie. 2006. PMID: 16886710 French.

5

Les heures optimales d'administration des corticoïdes.

Dridi D, Attia MB, Aouam K, Bouzouita K, Boughattas NA, Alain Reinberg. Dridi D, et al. Among authors: bouzouita k. Therapie. 2006 Mar-Apr;61(2):161-9. doi: 10.2515/therapie:2006021. Therapie. 2006. PMID: 27393318 French.

6

Optimization of the separation conditions of tetracyclines on a preselected reversed-phase column with embedded urea group.

Kallel L, Ben Attia M, Bouzouita K, Aissa P, Trabelsi H. Kallel L, et al. Among authors: bouzouita k. J Sep Sci. 2006 May;29(7):929-35. doi: 10.1002/jssc.200500344. J Sep Sci. 2006. PMID: 16833224

7

[Dose-effect of adrenaline nebulization in asthma: comparative study with salbutamol].

Elatrous S, Elidrissi H, Trabelsi H, Boujdaria R, Boussarsar M, Ouannes L, Bouzouita K, Nouira S, Abroug MF. Elatrous S, et al. Among authors: bouzouita k. Rev Pneumol Clin. 1997;53(4):187-91. Rev Pneumol Clin. 1997. PMID: 9616817 Clinical Trial. French.

8

LC determination and degradation study of droperidol.

Trabelsi H, Guettat S, Bouzouita K, Safta F. Trabelsi H, et al. Among authors: bouzouita k. J Pharm Biomed Anal. 2002 May 15;28(3-4):453-62. doi: 10.1016/s0731-7085(01)00597-0. J Pharm Biomed Anal. 2002. PMID: 12008124

9

Reversed-phase liquid chromatography of lisinopril conformers.

Bouabdallah S, Trabelsi H, Bouzouita K, Sabbah S. Bouabdallah S, et al. Among authors: bouzouita k. J Biochem Biophys Methods. 2002 Dec 31;54(1-3):391-405. doi: 10.1016/s0165-022x(02)00140-9. J Biochem Biophys Methods. 2002. PMID: 12543514

10

Zero-crossing derivative spectrophotometry for the determination of haloperidol in presence of parabens.

Ouanês S, Kallel M, Trabelsi H, Safta F, Bouzouita K. Ouanês S, et al. Among authors: bouzouita k. J Pharm Biomed Anal. 1998 Jul;17(3):361-4. doi: 10.1016/s0731-7085(97)00174-x. J Pharm Biomed Anal. 1998. PMID: 9656144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters